Indeed, some lipid metabolism-related proteins, such as SCD1 [39], sphingomyelin synthase [44], and peroxisome proliferator-activated receptor-δ [45], were reported to predict the response to sorafenib in HCC. The gene discussed is SCD; the disease is hepatocellular carcinoma.